OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2015
(5)
2013
(5)
2020
(3)
2024
(2)
2017
(2)
2022
(1)
2018
(1)
2016
(1)
2012
(1)
2011
(1)
2010
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
Not available
S-EPMC5655733
|
biostudies-literature
Cite
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma.
Not available
S-EPMC4410296
|
biostudies-literature
Cite
Identification of four new susceptibility loci for testicular germ cell tumour.
Not available
S-EPMC4846317
|
biostudies-literature
Cite
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).
Not available
S-EPMC3753507
|
biostudies-literature
Cite
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial.
Not available
S-EPMC6983941
|
biostudies-literature
Cite
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Not available
S-EPMC4410298
|
biostudies-literature
Cite
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.
Not available
S-EPMC3773909
|
biostudies-literature
Cite
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Not available
S-EPMC3603440
|
biostudies-literature
Cite
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer.
Not available
S-EPMC5849160
|
biostudies-literature
Cite
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
Not available
S-EPMC3680037
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
